These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 39329206)

  • 1. PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review).
    Zhang X; Wang H; Yuan Y; Zhang J; Yang J; Zhang L; He J
    Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39329206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PPM1G is associated with the progression and poor prognosis of hepatocellular carcinoma.
    Xiong DL; Li Q; Wang H; Jin WL; Fan XM; Ma YY
    Cancer Biomark; 2022; 34(1):13-22. PubMed ID: 34366322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
    Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
    Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
    Lin YR; Yang WJ; Yang GW
    Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
    D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
    Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
    Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
    Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
    Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
    Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
    Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ARF tumor suppressor targets PPM1G/PP2Cγ to counteract NF-κB transcription tuning cell survival and the inflammatory response.
    Hyder U; McCann JL; Wang J; Fung V; Bayo J; D'Orso I
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32594-32605. PubMed ID: 33288725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.
    Scaggiante B; Kazemi M; Pozzato G; Dapas B; Farra R; Grassi M; Zanconati F; Grassi G
    World J Gastroenterol; 2014 Feb; 20(5):1268-88. PubMed ID: 24574801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
    Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma.
    Wu Z; Zhang L; Li X; Liu L; Kuang T; Qiu Z; Deng W; Wang W
    Sci Rep; 2024 May; 14(1):10662. PubMed ID: 38724606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.
    Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B
    Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.
    Chen J; Li J; Sun H; Hu T; Wang Y; Kang G; Cao M; Li X
    Carcinogenesis; 2023 May; 44(1):93-104. PubMed ID: 36349938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.